Hung Trinh: Researchers have re-engineered immune cells that penetrate and kill solid tumors

Hung Trinh: Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data

Hung Trinh: Natera Announces Enrollment of First Patients in SAGITTARIUS

Hung Trinh: Groundbreaking Stanford University cancer treatment received FDA designation

Breakthrough of solid tumor treatment: CAR-NK immunotherapy, review by Hung Trinh

Hung Trinh: Optimizing the post-CAR T monitoring period in recipients of Axi-cel, Tisa-cel, and Liso-cel by Nausheen Ahmed et al.

Hung Trinh: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Hung Trinh: The use of chimeric antigen receptor (CAR)-T cells has demonstrated excellent results in B-lymphoid malignancies

Hung Trinh: Top 10 CDMO ranking based on sales revenue and operation

Hung Trinh: A novel CAR-Enhancer to prevent relapse after CAR-T Therapy by Dana-Farber Cancer Institute